CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | MOORE JOHN R General Counsel | Sale | −17,150 | $6.61 | $113K | 3,000 |
| 2022-06-07 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −973 | 196,921 | ||
| 2022-06-07 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −17,150 | 188,172 | ||
| 2022-06-06 | MOORE JOHN R General Counsel | Option exercise | +13,934 | $1.93 | $27K | 16,934 |
| 2022-06-06 | MOORE JOHN R General Counsel | Sale | −13,934 | $6.03 | $84K | 3,000 |
| 2022-06-06 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −13,934 | 197,894 | ||
| 2022-06-03 | MOORE JOHN R General Counsel | Option exercise | +15,230 | $1.93 | $29K | 18,230 |
| 2022-06-03 | MOORE JOHN R General Counsel | Sale | −15,230 | $6.05 | $92K | 3,000 |
| 2022-06-03 | MOORE JOHN R General Counsel | Option exercise · Stock Option (Right to Buy) | −15,230 | 211,828 | ||
| 2022-05-23 | Carruthers R Michael Chief Financial Officer | Option exercise | +9,000 | $0.71 | $6K | 12,000 |
| 2022-05-23 | Carruthers R Michael Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −9,000 | $0.71 | $6K | 207,122 |
| 2022-05-18 | ORBIMED ADVISORS LLC Director | Purchase | +138,000 | $7.21 | $995K | 13,497,456 |
| 2022-05-18 | Thompson Peter A. Director | Purchase | +138,000 | $7.21 | $995K | 13,497,456 |
| 2022-05-16 | MOORE JOHN R General Counsel | Sale | −10,800 | $7.42 | $80K | 3,000 |
| 2022-05-01 | Carruthers R Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +15,625 | 15,625 | ||
| 2022-05-01 | Derakhshan Behrad Chief Business Officer | Grant or award · Restricted Stock Units | +15,625 | 15,625 | ||
| 2022-05-01 | MOORE JOHN R General Counsel | Grant or award · Restricted Stock Units | +15,625 | 15,625 | ||
| 2022-05-01 | Russell Alan J Chief Scientific Officer | Grant or award · Restricted Stock Units | +15,625 | 15,625 | ||
| 2022-05-01 | Donovan Joanne M. CMO | Grant or award · Restricted Stock Units | +31,250 | 31,250 | ||
| 2022-05-01 | KOCH KEVIN President and CEO | Grant or award · Restricted Stock Units | +31,250 | 31,250 |
Page 21 of 26 · 509 trades